Insulin Delivery Systems to Be a US 15.5 Billion Market by 2018

Rising diabetic population, government efforts at boosting the insulin markets in emerging countries and rising uptake of disposable insulin pens in US will propel the market, says RNCOS.

 

Noida, UP -- (SBWIRE) -- 11/26/2014 -- As per the new research report by RNCOS, “Global Insulin Delivery Devices Market Outlook 2018”, manufacturers and service providers are recognizing and catering to the special needs of diabetics. As per our forecast, the global insulin delivery systems market will grow to US$ 15.62 Billion by 2018. Insulin delivery systems include insulin syringes, pens, pumps, and jet injectors. According to our study, insulin syringes and pens dominate the global insulin delivery systems market. However, the market penetration of both insulin pumps and needle-free injection jets is also rising due to technological advances. Growth is mainly being observed in insulin pens, wherein, the market of disposable insulin pens is rising rapidly in the US and reusable insulin pens are finding increased usage in China.

Research Analysis & Highlights
The report is spread in over 115 pages and provides an in-depth research and rational analysis of the current status and future prospect of the insulin delivery systems market. The study presents a global picture about the prevalence of diabetes and the overall market for insulin delivery systems. It includes a geographical analysis of insulin delivery systems in key diabetic countries. The research further covers the market for main insulin delivery systems along with their current and future projections. RNCOS’ study leads to the proposition that innovation has huge scope in this field and we have explored and provided information on some of the emerging insulin delivery devices. Finally, an analysis of the leading market players provides a holistic understanding to the reader. Players covered include Novo Nordisk, Eli Lilly, Sanofi-Aventis, Medtronic, Roche, and Becton Dickenson and Company, which together account for more than 90% of the global market.

Some of the key highlights of the report include the following:
- Growth Drivers like Rising popularity of Artificial Pancreas and Home Infusion Therapy
- Regional Wise Market Segmentation of Insulin Delivery Devices
- Novo-Nordisk-Leader in Diabetes Care Market
- Emerging Trends in Insulin Delivery Devices with emphasis on insulin pumps, Insulin sprays and insulin inhalers.

For Free Sample of this report visit: http://www.rncos.com/Report/IM723.htm

Check Related Reports on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.